首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice
【24h】

Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice

机译:胆固醇7α-羟化酶/类固醇反应元件结合蛋白2 / microRNA-33a轴对胆固醇和胆汁酸稳态的调节

获取原文
获取原文并翻译 | 示例
           

摘要

Bile acid synthesis not only produces physiological detergents required for intestinal nutrient absorption, but also plays a critical role in regulating hepatic and whole-body metabolic homeostasis. We recently reported that overexpression of cholesterol 7α-hydroxylase (CYP7A1) in the liver resulted in improved metabolic homeostasis in Cyp7a1 transgenic (Cyp7a1-tg) mice. This study further investigated the molecular links between bile acid metabolism and lipid homeostasis. Microarray gene profiling revealed that CYP7A1 overexpression led to marked activation of the steroid response element-binding protein 2 (SREBP2)-regulated cholesterol metabolic network and absence of bile acid repression of lipogenic gene expression in livers of Cyp7a1-tg mice. Interestingly, Cyp7a1-tg mice showed significantly elevated hepatic cholesterol synthesis rates, but reduced hepatic fatty acid synthesis rates, which was accompanied by increased 14C-glucose-derived acetyl-coenzyme A incorporation into sterols for fecal excretion. Induction of SREBP2 also coinduces intronic microRNA-33a (miR-33a) in the SREBP2 gene in Cyp7a1-tg mice. Overexpression of miR-33a in the liver resulted in decreased bile acid pool, increased hepatic cholesterol content, and lowered serum cholesterol in mice. Conclusion: This study suggests that a CYP7A1/SREBP2/miR-33a axis plays a critical role in regulation of hepatic cholesterol, bile acid, and fatty acid synthesis. Antagonism of miR-33a may be a potential strategy to increase bile acid synthesis to maintain lipid homeostasis and prevent nonalcoholic fatty liver disease, diabetes, and obesity. (Hepatology 2013;53:1111-1121).
机译:胆汁酸的合成不仅产生肠道营养吸收所需的生理清洁剂,而且在调节肝脏和全身代谢稳态方面也起着关键作用。我们最近报道说,肝脏中胆固醇7α-羟化酶(CYP7A1)的过度表达导致Cyp7a1转基因(Cyp7a1-tg)小鼠体内代谢稳态得到改善。这项研究进一步调查了胆汁酸代谢和脂质稳态之间的分子联系。基因芯片的基因分析表明,CYP7A1的过表达导致Cyp7a1-tg小鼠肝脏中类固醇反应元件结合蛋白2(SREBP2)调节的胆固醇代谢网络的激活和胆汁酸对脂肪基因表达的抑制。有趣的是,Cyp7a1-tg小鼠显示出肝胆固醇合成速率显着提高,但肝脂肪酸合成速率降低,并伴随着14C-葡萄糖衍生的乙酰辅酶A掺入固醇中以进行粪便排泄。 SREBP2的诱导还可以在Cyp7a1-tg小鼠的SREBP2基因中共诱导内含子microRNA-33a(miR-33a)。肝脏中miR-33a的过度表达导致小鼠胆汁酸池减少,肝胆固醇含量增加和血清胆固醇降低。结论:这项研究表明CYP7A1 / SREBP2 / miR-33a轴在调节肝胆固醇,胆汁酸和脂肪酸合成中起关键作用。 miR-33a的拮抗作用可能是增加胆汁酸合成以维持脂质稳态并预防非酒精性脂肪肝,糖尿病和肥胖症的潜在策略。 (Hepatology 2013; 53:1111-1121)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号